Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446206
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-22
Brief Title:
Adebrelimab Plus Chemotherapy Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer
Sponsor:
The First Hospital of Jilin University
Organization:
The First Hospital of Jilin University
Organization Data
Organization:
The First Hospital of Jilin University
Class:
OTHER
Study ID:
2024-HS-022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Hospital of Jilin University
Lead Sponsor Class:
OTHER
Responsible Party:
Ziling Liu
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Hospital of Jilin University
Old Name:
None
Old Organization:
None